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Abstract
Deep learning models exhibit state-of-the-art performance for many predictive
healthcare tasks using electronic health records (EHR) data, but these models
typically require training data volume that exceeds the capacity of most healthcare
systems. External resources such as medical ontologies are used to bridge the
data volume constraint, but this approach is often not directly applicable or useful
because of inconsistencies with terminology. To solve the data insufficiency chal-
lenge, we leverage the inherent multilevel structure of EHR data and, in particular,
the encoded relationships among medical codes. We propose Multilevel Medical
Embedding (MiME) which learns the multilevel embedding of EHR data while
jointly performing auxiliary prediction tasks that rely on this inherent EHR struc-
ture without the need for external labels. We conducted two prediction tasks, heart
failure prediction and sequential disease prediction, where MiME outperformed
baseline methods in diverse evaluation settings. In particular, MiME consistently
outperformed all baselines when predicting heart failure on datasets of different
volumes, especially demonstrating the greatest performance improvement (15% rel-
ative gain in PR-AUC over the best baseline) on the smallest dataset, demonstrating
its ability to effectively model the multilevel structure of EHR data.
1 Introduction
The rapid growth of electronic health record (EHR) data has motivated use of deep learning models
and demonstrated state-of-the-art performance in diagnostics [26, 13, 12, 27], disease detection [14,
10, 17], risk prediction [20, 32], and patient subtyping [3, 6]. However, training optimal deep learning
models typically requires a large volume (i.e. number of patient records and features per record)
Most health systems do not have the data volume required to optimize performance of these models,
especially for less common services (e.g. intensive care units (ICU)) or rare conditions.
External resources, particularly medical ontologies have been used to address data volume insuffi-
ciencies [12, 31, 7]. For example [12], latent embedding of a clinical code (e.g. diagnosis code) can
be learned as a convex combination of the embeddings of the code itself and its ancestors on the
ontology graph. However, medical ontologies are often not available or not directly applicable due to
the nonstandard, or idiosyncratic use of terminology and complex terminology mapping from one
health system’s EHR to another. For example, many clinics still use their own in-house terminologies
∗Work done at Georgia Institute of Technology.
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Figure 1: Symbolic representation of a single visit of a patient. Red denotes diagnosis codes, and blue
denotes medication/procedure codes. A visit encompasses a set of codes, as well as a hierarchical
structure and heterogeneous relations among these codes. For example, while both Acetaminophen
and IV fluid form an explicit relationship with Fever, they also are correlated with each other as
descendants of Fever.
for medications and lab tests, which do not conform with the standard medical ontologies such as
Anatomical Therapeutic Chemical (ATC) Classification system and Logical Observation Identifiers
Names and Codes (LOINC).
As an alternative, we explored how the inherent multilevel structure of EHR data could be leveraged
to improve learning efficiency. The hierarchical structure of EHR data begins with the patient,
followed by visits, then diagnosis codes within visits, which are then linked to treatment orders
(e.g. medications, procedures). This hierarchical structure reveals influential multilevel relationships,
especially between diagnosis codes and treatment codes. For example, a diagnosis fever can lead to
associated treatments such as acetaminophen (medication) and IV fluid (procedure). We examine
whether this multilevel structure could be leveraged to obtain a robust model under small data volume.
To the best of our knowledge, none of the existing works leverage this multilevel structure in EHR.
Rather, they flatten EHR data as a set of independent codes [18, 38, 11, 12, 14, 10, 13, 27, 2], which
ignores hierarchical relationships among medical codes within visits.
We propose Multilevel Medical Embedding) (MiME) to simultaneously transform the inherent multi-
level structure of EHR data into multilevel embeddings, while jointly performing auxiliary prediction
tasks that reflect this inherent structure without the need for external labels. Modeling the inher-
ent structure among medical codes enables us to accurately capture the distinguishing patterns of
different patient states. The auxiliary tasks inject the hierarchical knowledge of EHR data into the
embedding process such that the main task can borrow prediction power from related auxiliary tasks.
We conducted two prediction tasks, heart failure prediction and sequential disease prediction, where
MiME outperformed baseline methods in diverse evaluation settings. In particular, for heart failure
prediction on datasets of different volumes, MiME consistently outperformed all baseline models.
Especially, MiME showed the greatest performance improvement (15% relative gain in PR-AUC over
the best baseline) for the smallest dataset, demonstrating its ability to effectively model the multilevel
structure of EHR data.
2 Method
EHR data can be represented by a common hierarchy that begins with individual patient records,
where each patient record consists of a sequence of visits. In a typical visit,a physician gives a
diagnosis to a patient and then order medications or procedures based on the diagnosis. This process
generates a set of treatment (medication and procedure) codes and a relationship among diagnosis
and treatment codes (see Figure 1). MiME is designed to explicitly capture the relationship between
the diagnosis codes and the treatment codes within visits.
2.1 Notations of MiME
Assume a patient has a sequence of visits V(1), . . . ,V(t) over time, where each visit V(t) contains a
varying number of diagnosis (Dx) objects O(t)1 , . . . ,O(t)|V(t)|. Each O
(t)
i consists of a single Dx code
d
(t)
i ∈ A and a set of associated treatments (medications or procedures)M(t)i . Similarly, eachM(t)i
consists of varying number of treatment codes m(t)i,1, . . . ,m
(t)
i,|M(t)i |
∈ B. To reduce clutter, we omit
2
Table 1: Notations for MiME. Note that the dimension size z is used in many places due to the use of
skip-connections, which will be described in section 2.2.
Notation Definition
A Set of unique diagnosis codes
B Set of unique treatment codes (medications and procedures)
h A vector representation of a patient
V(t) A patient’s t-th visit, which contains diagnosis objects O(t)1 , . . . ,O(t)|V(t)|
v(t) ∈ Rz A vector representation of V(t)
O(t)i i-th diagnosis object of t-th visit consisting of Dx code d(t)i and treatment codesM(t)i
o
(t)
i ∈ Rz A vector representation of O(t)i
p(d
(t)
i |o(t)i ), p(m(t)i,j |o(t)i ) Auxiliary predictions, respectively for a Dx code and a treatment code based on o(t)i
d
(t)
i ∈ A Dx code of diagnosis object O(t)i
M(t)i a set of treatment codes associated with i-th Dx code d(t)i in visit t
m
(t)
i,j ∈ B j-th treatment code ofM(t)i
g(d
(t)
i ,m
(t)
i,j ) A function that captures the interaction between d
(t)
i and m
(t)
i,j
f(d
(t)
i ,M(t)i ) A function that computes embedding of diagnosis object o(t)i
r(·) ∈ Rz A helper notation for extracting d(t)i or m(t)i,j ’s embedding vector
the superscript (t) indicating t-th visit, when we are discussing a single visit. Table 1 summarizes
notations we will use throughout the paper.
In Figure 1, there are five Dx codes, hence five Dx objects O(t)1 , . . . ,O(t)5 . More specifically, the
first Dx object O1 has d(t)1 = Fatigue as the Dx code, but no treatment codes. O2, on the other
hand, has Dx code d(t)2 = Cough and two associated treatment codes m
(t)
2,1 = Benzonatate and
m
(t)
2,2 = Acetaminophen. In this case, we can use g(d
(t)
2 ,m
(t)
2,1) to capture the interaction between Dx
code Cough and treatment code Benzonatate, which will be fed to f(d(t)2 ,M(t)2 ) to obtain the vector
representation of Dx object o(t)2 . Using the five Dx object embeddings o
(t)
1 , . . . ,o
(t)
5 , we can obtain a
visit embedding v(t). In addition, some treatment codes (e.g. Acetaminophen) can be shared by two
or more Dx codes (e.g. Cough, Fever), if the doctor ordered a single medication for more than one
diagnosis. Then each Dx object will have its own copy of the treatment code attached to it, in this
case denoted, m(t)2,2 and m
(t)
3,1, respectively.
2.2 Description of MiME
Multilevel Embedding As discussed earlier, previous approaches often flatten a single visit such
that Dx codes and treatment codes are packed together so that a single visit V(t) can be expressed as a
binary vector x(t) ∈ {0, 1}|A|+|B| where each dimension corresponds to a specific Dx and treatment
code. Then a patient’s visit sequence is encoded as:
v(t) = σ(Wxx
(t) + bx)
h = h(v(1),v(2), . . . ,v(t))
where Wx is the embedding matrix that converts the binary vector x to a lower-dimensional visit
representation3, σ a non-linear activation function such as sigmoid or rectified linear unit (ReLU),
h(·) a function that maps a sequence of visit representations v(0), . . . ,v(t) to a patient representation
h. In contrast, MiME effectively derives a visit representation v(t), than can be plugged into any h(·)
for the downstream prediction task. h(·) can simply be an RNN or a combination of RNNs and CNN
and attention mechanisms [1].
MiME explicitly captures the hierarchy between Dx codes and treatment codes depicted in Figure 1.
Figure 2 illustrates how MiME builds the representation of V (omitting the superscript (t)) in a bottom-
up fashion via multilevel embedding. In a single Dx object Oi, a Dx code di and its associated
treatment codesMi are used to obtain a vector representation of Oi, oi. Then multiple Dx object
embeddings o0, . . . ,o|V| in a single visit are used to obtain a visit embedding v, which in turn forms
3We omit bias variables throughout the paper to reduce clutter.
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Figure 2: Prediction model using MiME. Codes are embedded into multiple levels: diagnosis-level,
visit-level, and patient-level. Final prediction p(y|h) is based on the patient representation h, which is
derived from visit representations v(0),v(1), . . ., where each v(t) is generated using MiME framework.
As shown in the Treatment level, MiME explicitly captures the interactions between a diagnosis code
and the associated treatment codes. MiME also uses those codes as auxiliary prediction targets to
improve generalizability when large training data are not available.
a patient embedding h with other visit embeddings. The formulation of MiME is as follows:
v = σ
(
Wv
( |V|∑
i
f(di,Mi)︸ ︷︷ ︸
F: used for skip-connection
))
+ F (1)
f(di,Mi) = oi = σ
(
Wo
(
r(di) +
|Mi|∑
j
g(di,mi,j)︸ ︷︷ ︸
G: used for skip-connection
))
+G (2)
g(di,mi,j) = σ
(
Wmr(di)
) r(mi,j) (3)
where Eq. (1), Eq. (2) and Eq. (3) describe MiME in a top-down fashion, respectively corresponding
to Visit level, Diagnosis level and Treatment level in Figure 2.
In Eq. (1), a visit embedding v is obtained by summing Dx object embeddings o1, . . . ,o|V|, which are
then transformed with Wv ∈ Rz×z . σ is a non-linear activation function such as sigmoid or rectified
linear unit (ReLU). In Eq. (2), oi is obtained by summing r(di) ∈ Rz , the vector representation of
the Dx code di, and the effect of the interactions between di and its associated treatmentsMi, which
are then transformed with Wo ∈ Rz×z . The interactions captured by g(di,mi,j) are added to the
r(di), which can be interpreted as adjusting the diagnosis representation according to its associated
treatments (medications and procedures). Note that in both Eq. (1) and Eq. (2), F and G are used to
denote skip-connections [23].
In Eq. (3), the interaction between a Dx code embedding r(di) and a treatment code embedding
r(mi,j) is captured by element-wise multiplication. Weight matrixWm ∈ Rz×z sends the Dx code
embedding r(di) into another latent space, where the interaction between di and the corresponding
mi,j can be effectively captured. The formulation of Eq. (3) was inspired by recent developments in
bilinear pooling technique [37, 21, 19, 24], which we discuss in more detail in Appendix A. With
Eq. (3) in mind, G in Eq. (2) can also be interpreted as r(di) being skip-connected to the sum of
interactions g(di,mi,j).
4
Joint Training with Auxiliary Tasks Patient embedding h is often used for specific prediction tasks,
such as heart failure prediction or mortality. The representation power of h comes from properly
capturing each visit V(t), and modeling the longitudinal aspect with the function h(v0, . . . ,vt). Since
the focus of this work is on modeling a single visit V(t), we perform auxiliary predictions as follows:
dˆ
(t)
i = p(d
(t)
i |o(t)i ) = softmax(Udo(t)i ) (4)
mˆ
(t)
i,j = p(m
(t)
i,j |o(t)i ) = σ(Umo(t)i ) (5)
Laux = −λaux
T∑
t
( |V(t)|∑
i
(
CE(d
(t)
i , dˆ
(t)
i ) +
|M(t)i |∑
j
CE(m
(t)
i,j , mˆ
(t)
i,j )
))
(6)
Given Dx object embeddings o(t)1 , . . . ,o
(t)
|V(t)|, while aggregating them to obtain v
(t) as in Eq. (1),
MiME predicts the Dx code d(t)i , and the associated treatment code m
(t)
i,j as depicted by Figure 2. In
Eq. (4) and Eq. (5), Ud ∈ R|A|×z and Um ∈ R|B|×z are weight matrices used to compute the the
prediction of Dx code dˆ(t)i and the prediction of the treatment code mˆ
(t)
i,j , respectively. In Eq. (6), T
denotes the total number of visits the patient made, CE(·, ·) the cross-entropy function and λaux the
coefficient for the auxiliary loss term. We used the softmax function for predicting d(t)i since in a
single Dx object O(t)i , there is only one Dx code involved. However, there could be no (or many)
treatment codes associated with O(t)i , and therefore we used |B| number of sigmoid functions for
predicting each treatment code.
Auxiliary tasks are based on the inherent structure of the EHR data, and require no additional
labeling effort. These auxiliary tasks guide the model to learn Dx object embeddings o(t)i that are
representative of the specific codes involved with it. Correctly capturing the events within a visit is
the basis of all downstream prediction tasks, and these general-purpose auxiliary tasks, combined
with the specific target task, encourage the model to learn visit embeddings v(t) that are not only
tuned for the target prediction task, but also grounded in general-purpose foundational knowledge.
3 Experiments
In this section, we first describe the dataset and the baseline models, and present evaluation results.
The source code of MiME is publicly available at https://github.com/mp2893/mime.
3.1 Source of Data
We conducted all our experiments using EHR data provided by Sutter Health. The dataset was
constructed for a study designed to predict a future diagnosis of heart failure, and included EHR data
from 30,764 senior patients 50 to 85 years of age. We extracted the diagnosis codes, medication
codes and the procedure codes from encounter records, and related orders. We used Clinical
Classification Software for ICD9-CM4 to group the ICD9 diagnosis codes into 388 categories.
Generic Product Identifier Drug Group5 was used to group the medication codes into 99 categories.
Clinical Classifications Software for Services and Procedures6 was used to group the CPT procedure
codes into 1,824 categories. Any code that did not fit into the grouper formed its own category.
Table 2 summarizes data statistics.
3.2 Baseline Models
First, we use Gated Recurrent Units (GRU) [9] with different embedding strategies to map visit
embedding sequence v(1), . . . ,v(T ) to a patient representation h:
• raw: A single visit V(t) is represented by a binary vector x(t) ∈ {0, 1}|A|+|B|. Only the
dimensions corresponding to the codes occurring in that visit is set to 1, and the rest are 0.
4https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp
5http://www.wolterskluwercdi.com/drug-data/medi-span-electronic-drug-file/
6https://www.hcup-us.ahrq.gov/toolssoftware /ccs_svcsproc/ccssvcproc.jsp
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Table 2: Statistics of the dataset
# of patients 30,764
# of visits 616,073
Avg. # of visits per patient 20.0
# of unique codes 2,311 (Dx:388, Rx:99, Proc:1,824)
Avg. # of Dx per visit 1.93 (Max: 29)
Avg. # of Rx per diagnosis 0.31 (Max: 17)
Avg. # of Proc. per diagnosis 0.36 (Max: 10)
• linear: The binary vector x(t) is linearly transformed to a lower-dimensional vector v(t) =
Wxx
(t) where Wx ∈ Rb×(|A|+|B|) is the embedding matrix. This is equivalent to taking the
vector representations of the codes (i.e. columns of the embedding matrix Wx) in the visit V(t),
and summing them up to derive a single vector v(t) ∈ Rb.
• sigmoid, tanh, relu: The binary vector x(t) is transformed to a lower-dimensional vector v(t) =
σ(Wxx
(t)) where we use either sigmoid, tanh, or ReLU for σ(·) to add non-linearity to linear.
• sigmoidmlp, tanhmlp, relumlp: We add one more layer to sigmoid, tanh and relu to increase
their expressivity. The visit embedding is now v(t) = σ(Wx2σ(Wx1x
(t))) where σ is either
sigmoid, tanh or ReLU. We do not test linearmlp since two consecutive linear layers can be
collapsed to a single linear layer.
Second, we also compare with two advanced embedding methods that are specific designed for
modeling EHR data.
• Med2Vec: We use Med2Vec [11] to learn visit representations, and use those fixed vectors
as input to the prediction model. We test this model as a representative case of unsupervised
embedding approach using EHR data.
• GRAM: We use GRAM [12], which is equivalent to injecting domain knowledge (ICD9 Dx code
tree) to tanh via attention mechanism. We test this model as a representative case of incorporating
external domain knowledge.
3.3 Prediction Tasks
Heart failure prediction The objective is to predict the first diagnosis of heart failure (HF), given an
18-months observation records discussed in section 3.1. Among 30,764 patients, 3,414 were case
patients who were diagnosed with HF within a 1-year window after the 18-months observation. The
remaining 27,350 patients were controls. The case-control selection criteria are detailed in [39] and
summarized in Appendix B. While an accurate prediction of HF can save a large amount of costs and
lives [33], this task is also suitable for assessing how well a model can learn the relationship between
the external label (i.e. the label information is not inherent in the EHR data) and the features (i.e.
codes).
We applied logistic regression to the patient representation h to obtain a value between 0 (no HF
onset) and 1 (HF onset). All models were trained end-to-end except Med2Vec. We report Area under
the Precision-Recall Curve (PR-AUC) in the experiment and Area under the Receiver Operating
Characteristic (ROC-AUC) in the appendix, as PR-AUC is considered a better measure for imbalanced
data like ours [34, 16]. Implementation and training configurations are described in Appendix C. We
also performed sequential disease prediction (SDP) (predicting all diagnoses of the next visit at every
timestep) where MiME demonstrated superior performance over all baseline models. The detailed
description and results of SDP are provided in Appendix H and Appendix I respectively.
3.4 Experiment 1: Varying the Data Size
To evaluate MiME’s performance in another perspective, we created four datasets E1, E2, E3, E4
from the original data such that each dataset consisted of patients with varying maximum sequence
length Tmax (i.e. maximum number of visits). In order to simulate a new hospital collecting patient
records over time, we increased Tmax for each dataset such that 10, 20, 30, 150 for E1, E2, E3, E4
respectively. Each dataset had 6299 (414 cases), 15794 (1177 cases), 21128 (1848 cases), 27428
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Figure 3: Test PR-AUC of HF prediction for increasing data size. A table with the results of all
baseline models is provided in Appendix F
(3173 cases) patients respectively. For MiME aux, we used the same 0.015 for the auxiliary loss
coefficient λaux.
Figure 3 shows the test PR-AUC for HF prediction across all datasets (loss and ROC-AUC are
described in Appendix G). Again we show the strongest activation functions tanh and tanhmlp here
and provide the full table in Appendix F. We can readily see that MiME outperforms all baseline
models across all datasets. However, the performance gap between MiME and the baselines are larger
in datasets E1, E2 than in datasets E3, E4, confirming our assumption that exploiting the inherent
structure of EHR can alleviate the data insufficiency problem. Especially for the smallest dataset E1,
MiME aux (0.2831 PR-AUC) demonstrated significantly better performance than the best baseline
tanhmlp (0.2462 PR-AUC), showing 15% relative improvement.
It is notable that MiME consistently outperformed GRAM in both Table 3 and Figure 3 in terms of test
loss and test PR-AUC. To be fair, GRAM was only using Dx code hierarchy (thus ungrouped 5814
Dx codes were used), and no additional domain knowledge regarding treatment codes. However,
the experiment results tell us that even without resorting to external domain knowledge, we can still
gain improved predictive performance by carefully studying the EHR data and leveraging its inherent
structure.
3.5 Experiment 2: Varying Visit Complexity
Table 3: HF prediction performance on small datasets. Values in the parentheses denote standard
deviations from 5-fold random data splits. All models used GRU for mapping the visit embeddings
v(1), . . . ,v(T ) to a patient representation h. Two best values in each column are marked in bold. A
full table with all baselines is provided in Appendix D.
D1
(Visit complexity 0-15%)
(5608 patients, 464 cases)
D2
(Visit complexity 15-30%)
(5180 patients, 341 cases)
D3
(Visit complexity 30-100%)
(5231 patients, 383 cases)
test loss test PR-AUC test loss test PR-AUC test loss test PR-AUC
raw 0.2553 (0.0084) 0.2669 (0.0314) 0.2203 (0.0186) 0.2388 (0.0460) 0.2144 (0.0127) 0.3776 (0.0589)
linear 0.2562 (0.0108) 0.2722 (0.0354) 0.2200 (0.0187) 0.2403 (0.0229) 0.2021 (0.0176) 0.4339 (0.0411)
tanh 0.2648 (0.0124) 0.2707 (0.0138) 0.2186 (0.0182) 0.2479 (0.0512) 0.2025 (0.0151) 0.4415 (0.0532)
tanhmlp 0.2587 (0.0121) 0.2671 (0.0257) 0.2289 (0.0213) 0.2296 (0.0185) 0.2024 (0.0181) 0.4290 (0.0510)
Med2Vec 0.2601 (0.0186) 0.2771 (0.0288) 0.2171 (0.0170) 0.2356 (0.0309) 0.2044 (0.0129) 0.3813 (0.0240)
GRAM 0.2554 (0.0254) 0.2633 (0.0521) 0.2249 (0.0448) 0.2505 (0.0609) 0.2333 (0.0362) 0.3998 (0.0628)
MiME 0.2535 (0.0042) 0.2637 (0.0326) 0.2121 (0.0238) 0.2579 (0.0241) 0.1931 (0.0140) 0.4685 (0.0432)
MiME aux 0.2512 (0.0073) 0.2750 (0.0326) 0.2117 (0.0238) 0.2589 (0.0287) 0.1910 (0.0163) 0.4787 (0.0434)
Next, we conducted a series of experiments to confirm that MiME can indeed capture the relation-
ship between Dx codes and treatment codes, thus producing robust performance in small datasets.
Specifically, we created three small datasets D1, D2, D3 from the original data such that each dataset
consisted of patients with varying degree of Dx-treatment interactions (i.e. visit complexity). We
defined visit complexity as below to calculate for a patient the percentage of visits that have at least
two diagnosis codes associated with different sets of treatment codes,
visit complexity =
#V(t) where |set(M(t)1 , . . . ,M(t)|V(t)|)| ≥ 2
T
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where T denotes the total number of visits. For example, in Figure 1, the t-th visit V(t) has Fever
associated with no treatments, and Cough associated with two treatments. Therefore V(t) qualifies
as a complex visit. From the original dataset, we selected patients with a short sequence (less
than 20 visits) to simulate a hospital newly equipped with a EHR system, and there aren’t much
data collected yet. Among the patients with less than 20 visits, we used visit complexity ranges
0− 15%, 15− 30%, 30− 100% to create D1, D2, D3 consisting of 5608 (464 HF cases), 5180 (341
HF cases), 5231 (383 HF cases) patients respectively. For training MiME with auxiliary tasks, we
explored various λaux values between 0.01− 0.1, and found 0.015 to provide the best performance,
although other values also improved the performance in varying degrees.
Table 3 shows the HF prediction performance for the dataset D1, D2 and D3. To enhance readability,
we show here the results of the strongest activation function tanh and tanhmlp, and we report test
loss and test PR-AUC. The results of other activation functions and the test ROC-AUC are provided
in Appendix D and Appendix E.
Table 3 provides two important messages. First of all, both MiME and MiME aux show close to the best
performance in all datasets D1, D2 and D3, especially high complexity dataset D3.This confirms
that MiME indeed draws its power from the interactions between Dx codes and treatment codes, with
or without the auxiliary tasks. In D1, patients’ visits do not have much structure, that it makes little
difference whether we use MiME or not, and its performance is more or less similar to many baselines.
Second, auxiliary tasks indeed help MiME generalize better to patients unseen during training. In
all datasets D1, D2 and D3, MiME aux outperforms MiME in all measures, especially in D3 where it
shows PR-AUC 0.4787 (8.4% relative improvement over the best baseline tanh).
4 Related Work
Over the years, medical concept embedding has been an active research area. Some works tried to
summarize sparse and high-dimensional medical concepts into compressed vectors [15, 18]. In those
works, medical concepts were organized as temporal sequences, from which embeddings were derived.
Other works used latent layers of deep models for representing more abstract medical concepts
[14, 10, 13, 12, 27, 2]. For example, restricted Boltzmann Machines, stacked auto-encoders or multi-
layer neural networks were used to learn the representation of codes, visits, or patients [38, 28, 11].
Some works used medical ontologies to learn medical concept representations [12, 8]. Although all
works successfully learned concept embeddings for some task in varying degrees, they did not fully
utilize the multilevel structure or diagnosis-treatment relationship of EHR.
Recently, multiple code types in EHR gained more attentions. In [35], authors viewed different code
types separately, and tried to capture complex relationships across these disparate data types using
RNNs, but they did not explicitly address the hierarchy of EHR data. More recently in [30], the
authors tried to explicitly capture the interaction between a set of all diagnosis codes and a set of all
medication codes occurring in a visit. However, in their experiment, simply concatenating both sets
to obtain a visit vector outperformed other methods in many tasks. This suggests that disregarding
the diagnosis-specific Dx-Rx interaction and flattening all codes as sets is a suboptimal approach to
modeling EHR data.
As described in section 2.2, we employ auxiliary task strategy to train a robust model. Training a
model to predict multiple related targets has shown to improve model robustness in medical prediction
tasks in previous studies. For example, [5] used lab values as auxiliary targets to improve mortality
prediction performance. More recent studies [29, 22, 4] demonstrated improved prediction accuracy
when training a model with multiple related tasks such as mortality prediction and phenotyping.
5 Conclusion
In this work, we presented MiME, an integrated approach that simultaneously models hierarchical
inter-code relations into medical concept embedding while jointly performing auxiliary prediction
tasks. Through extensive empirical evaluation, MiME demonstrated impressive performance across all
benchmark tasks and its generalization ability to smaller datasets, especially outperforming baselines
in terms of PR-AUC in heart failure prediction. As we have established in this work that MiME can be
a good choice for modeling visits, in the future, we plan to extend MiME to include more fine-grained
medical events such as procedure outcomes, demographic information, and medication instructions.
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Table 4: Qualifying ICD-9 codes for heart failure
A Discussion of Bilinear Pooling
In Eq. (3), g(di,mi,j) uses a form of bilinear pooling to explicitly capture the interaction between
the Dx code and the treatment code. The original bilinear pooling [37] derives a scalar feature fi
between two embeddings x,y such that fi = xTWiy where Wi is a trainable weight matrix. Since
we typically extract many features f0, . . . , fi, to capture the interaction between two embeddings,
bilinear pooling requires us to train multiple weight matrices (i.e. weight tensor). Due to this
requirement, researchers developed more efficient methods such as compact bilinear pooling [21, 19]
and low-rank bilinear pooling [24], which is used in this work.
B Heart Failure Case-Control Selection Criteria
Case patients were 40 to 85 years of age at the time of HF diagnosis. HF diagnosis (HFDx) is
defined as: 1) Qualifying ICD-9 codes for HF appeared in the encounter records or medication orders.
Qualifying ICD-9 codes are displayed in Table 4. 2) a minimum of three clinical encounters with
qualifying ICD-9 codes had to occur within 12 months of each other, where the date of diagnosis was
assigned to the earliest of the three dates. If the time span between the first and second appearances of
the HF diagnostic code was greater than 12 months, the date of the second encounter was used as the
first qualifying encounter. The date at which HF diagnosis was given to the case is denoted as HFDx.
Up to ten eligible controls (in terms of sex, age, location) were selected for each case, yielding an
overall ratio of 9 controls per case. Each control was also assigned an index date, which is the HFDx
of the matched case. Controls are selected such that they did not meet the operational criteria for
HF diagnosis prior to the HFDx plus 182 days of their corresponding case. Control subjects were
required to have their first office encounter within one year of the matching HF case patient’s first
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Table 5: HF prediction performance of all models on small datasets. Values in the parentheses denote
standard deviations from 5-fold random data splits. Two best values in each column are marked in
bold.
D1
(Visit complexity 0-15%, 5608 patients)
D2
(Visit complexity 15-30%, 5180 patients)
D3
(Visit complexity 30-100%, 5231 patients)
test loss test PR-AUC test loss test PR-AUC test loss test PR-AUC
raw 0.2553 (0.0084) 0.2669 (0.0314) 0.2203 (0.0186) 0.2388 (0.0460) 0.2144 (0.0127) 0.3776 (0.0589)
linear 0.2562 (0.0108) 0.2722 (0.0354) 0.2200 (0.0187) 0.2403 (0.0229) 0.2021 (0.0176) 0.4339 (0.0411)
sigmoid 0.2594 (0.0062) 0.2637 (0.0374) 0.2198 (0.0220) 0.2445 (0.0363) 0.2029 (0.0118) 0.4358 (0.0585)
tanh 0.2648 (0.0124) 0.2707 (0.0138) 0.2186 (0.0182) 0.2479 (0.0512) 0.2025 (0.0151) 0.4415 (0.0532)
relu 0.2601 (0.0107) 0.2546 (0.0109) 0.2288 (0.0244) 0.1957 (0.0217) 0.2083 (0.0124) 0.4100 (0.0276)
sigmoidmlp 0.2836 (0.0102) 0.1207 (0.0145) 0.2407 (0.0162) 0.1119 (0.0334) 0.2127 (0.0294) 0.3547 (0.1208)
tanhmlp 0.2587 (0.0121) 0.2671 (0.0257) 0.2289 (0.0213) 0.2296 (0.0185) 0.2024 (0.0181) 0.4290 (0.0510)
relumlp 0.2650 (0.0088) 0.2463 (0.0148) 0.2288 (0.0235) 0.1982 (0.0298) 0.2144 (0.0202) 0.3872 (0.0476)
Med2Vec 0.2601 (0.0186) 0.2771 (0.0288) 0.2171 (0.0170) 0.2356 (0.0309) 0.2044 (0.0129) 0.3813 (0.0240)
GRAM 0.2554 (0.0254) 0.2633 (0.0521) 0.2249 (0.0448) 0.2505 (0.0609) 0.2333 (0.0362) 0.3998 (0.0628)
MiME 0.2535 (0.0042) 0.2637 (0.0326) 0.2121 (0.0238) 0.2579 (0.0241) 0.1931 (0.0140) 0.4685 (0.0432)
MiME aux 0.2512 (0.0073) 0.2750 (0.0326) 0.2117 (0.0238) 0.2589 (0.0287) 0.1910 (0.0163) 0.4787 (0.0434)
office visit, and have at least one office encounter 30 days before or any time after the case’s HF
diagnosis date to ensure similar duration of observations among cases and controls.
C Training Details
All models were implemented in TensorFlow 1.4 [36], and trained with a system equipped with Intel
Xeon E5-2620, 512TB memories and 8 Nvidia Pascal Titan X’s. We used Adam [25] for optimization,
with the learning rate 1e− 3.
In all experiments, the reported results are averaged over 5-fold random data splits: training (70%),
validation (10%) and test (20%). All models were trained with the minibatch of 20 patients for
20,000 iterations to guarantee convergence. At every 100 iterations, we evaluated the loss value of
the validation set for early stopping.
For the non-linear activation functions in MiME, we used ReLU in all places except for the one in
Eq. (1) where we used sigmoid to benefit from its regularization effect. We avoid the vanishing
gradient problem by using the skip connections. Note that simply adding skip connections to
sigmoidmlp did not improve performance.
For the first experiment in section 3.5, size of the visit vector v was 128 in all baseline models
except raw. We ran a number of preliminary experiments with values 64, 128, 256 and 512, and
we concluded that 128 was sufficient for all models to obtain optimal performance, as the datasets
D1, D2 and D3 were rather small. For MiME, we adjusted the size of the embeddings z to match
the number of parameters to the baselines. Med2Vec was also trained to obtain 128 dimensional
visit vectors. Note that sigmoidmlp, tanhmlp, relumlp and GRAM used 128× 128 more parameters
than other models. We used L2 regularization with the coefficient 1e− 4 for all models. We did not
use any dropout technique. All models used GRU for the function h(v(1), . . . ,v(T )) as described in
section 3.3, the cell size of which was 128.
For the second experiment in section 3.4, where the models were trained on gradually larger datasets
E1, E2, E3 and E4, the size of v was set to 256 for all baseline models except raw. The same
adjustments were made to MiME as before, and the cell size of GRU was also set to 256.
D Heart Failure Prediction Performance on Datasets D1, D2 and D3, Full
Version
Table 5 shows the performance of all models on datasets D1, D2 and D3. An interesting finding is
that both sigmoid and tanh mostly outperform relu in both measures in D1, D2 and D3, although
ReLU is the preferred nonlinear activation for hidden layers in many studies . This seems due to the
regularizing effect of sigmoid and tanh functions. Whereas ReLU can produce outputs as high as
infinity, sigmoid and tanh have bounded outputs. Considering that sigmoid, tanh and relu all sum
up the code embeddings in a visit V(t) before applying the nonlinear activation, constraining the
output of the nonlinear activation seems to work favorably, especially in D3 where there are more
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codes per visit. This regularization benefit, however, diminishes as the dataset grows, which can be
confirmed by Table 7 in section F. In addition, as can be seen by the performance of sigmoidmlp,
sigmoid clearly suffers from the vanishing gradient problem as opposed to tanh or ReLU that have
larger gradient values.
E ROC-AUC of Heart Failure Prediction on Datasets D1, D2 and D3
Table 6: ROC-AUC of all models for HF prediction on small datasets. Values in the parentheses
denote standard deviations from 5-fold random data splits. Two best values in each column are
marked in bold.
D1
(Visit complexity 0-15%, 5608 patients)
D2
(Visit complexity 15-30%, 5180 patients)
D3
(Visit complexity 30-100%, 5231 patients)
raw 0.7424 (0.0153) 0.7508 (0.0254) 0.8130 (0.0315)
linear 0.7298 (0.0187) 0.7241 (0.0220) 0.8209 (0.0130)
sigmoid 0.7220 (0.0098) 0.7331 (0.0475) 0.8280 (0.0128)
tanh 0.7273 (0.0050) 0.7244 (0.0175) 0.8171 (0.0151)
relu 0.7326 (0.0133) 0.7078 (0.0181) 0.8166 (0.0211)
sigmoidmlp 0.5520 (0.0136) 0.5770 (0.0416) 0.7718 (0.0826)
tanhmlp 0.7215 (0.0188) 0.7058 (0.0261) 0.8080 (0.0258)
relumlp 0.7205 (0.0122) 0.7014 (0.0177) 0.7993 (0.0212)
Med2Vec 0.7447 (0.0194) 0.7515 (0.0243) 0.8325 (0.0254)
GRAM 0.7586 (0.0240) 0.6930 (0.0379) 0.7785 (0.0260)
MiME 0.7433 (0.0127) 0.7723 (0.0232) 0.8393 (0.0281)
MiME aux 0.7449 (0.0117) 0.7741 (0.0209) 0.8437 (0.0244)
Table 6 shows ROC-AUC of all models on datasets D1, D2 and D3. Except for D1 where patients
have low visit complexity, MiME again consistently outperforms all baseline models. However, the
ROC-AUC gap between MiME and baselines is not as great as PR-AUC. This is because ROC-AUC is
determined by sensitivity (i.e. recall, or true positive rate) and specificity (i.e. true negative rate). A
model achieves a high specificity if it can correctly identify as many negative samples as possible,
which is easier for problems with many negative samples and few positive samples. PR-AUC, on the
other hand, is determined by precision and recall. Therefore, for a model to achieve a high PR-AUC,
it must correctly retrieve as many positive samples as possible while ignoring negative samples,
which is harder for problems with few positive samples.
For heart failure (HF) prediction, achieving high specificity is relatively easy as there are way more
controls (i.e. negative samples) than cases (i.e. positive samples). However, correctly identifying
cases while ignoring controls requires a model to recognize what differentiates cases from controls.
This means paying attention to the details of the patient records, such as the relationship between the
diagnosis codes and treatment codes. That is why MiME shows significant improvement in PR-AUC
while showing moderate improvement in ROC-AUC. Also, this also explains why Med2Vec shows
very poor PR-AUC as opposed to its competitive ROC-AUC. Med2Vec only pays attention to the
co-occurrence of codes within a single visit, and not the interaction between diagnosis codes and
treatment codes. It can work as a very efficient code grouper (codes that often appear in the same visit
end up having similar code embeddings), leading to a increased ROC-AUC. But it cannot achieve a
high PR-AUC, as that code grouping loses much of the subtle interaction between diagnosis codes
and medication codes.
F Test PR-AUC on Datasets E1, E2, E3 and E4, Full Version
Table 7 shows the PR-AUC of all models on datasets E1, E2, E3 and E4. It is notable that some
baseline models show fluctuating performance as dataset grows. For example, tanhmlp showed
competitive performance in small datasets, but weaker performance in large datasets. relumlp, on the
other hand, did not stand out in small datasets, but became the best baseline in large datasets. Such
behaviors, along with the finding in Appendix D regarding the regularization effect, suggest that we
should carefully choose activation functions of our model depending on the dataset size.
G Test Loss and Test ROC-AUC on Datasets E1, E2, E3 and E4
Table 8 and Table 9 respectively shows the test loss and test ROC-AUC of all models on datasets of
varying sizes E1, E2, E3 and E4. Both MiME and MiME aux consistently outperformed all baselines
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Table 7: Test PR-AUC of HF prediction for increasing data size. Parentheses denote standard
deviations from 5-fold random data splits. The two strongest values in each column are marked bold.
E1 (6299 patients) E2 (15794 patients) E3 (21128 patients) E4 (27428 patients)
raw 0.2374 (0.0514) 0.3149 (0.0367) 0.3816 (0.0290) 0.4865 (0.0219)
linear 0.2303 (0.0467) 0.3200 (0.0353) 0.3806 (0.0271) 0.4939 (0.0159)
sigmoid 0.2354 (0.0355) 0.3260 (0.0392) 0.3851 (0.0235) 0.4823 (0.0195)
tanh 0.2192 (0.0407) 0.3235 (0.0441) 0.3884 (0.0310) 0.4973 (0.0262)
relu 0.2293 (0.0459) 0.3274 (0.0359) 0.3793 (0.0291) 0.4957 (0.0160)
sigmoidmlp 0.0843 (0.0154) 0.0919 (0.0110) 0.1333 (0.0047) 0.2221 (0.0146)
tanhmlp 0.2462 (0.0675) 0.3333 (0.0387) 0.3834 (0.0209) 0.4847 (0.0172)
relumlp 0.2353 (0.0335) 0.3111 (0.0494) 0.3976 (0.0235) 0.4983 (0.0229)
Med2Vec 0.2404 (0.0228) 0.3057 (0.0508) 0.3861 (0.0343) 0.4756 (0.0148)
GRAM 0.2349 (0.0424) 0.3118 (0.0337) 0.4002 (0.0113) 0.4936 (0.0199)
MiME 0.2711 (0.0308) 0.3589 (0.0533) 0.4041 (0.0231) 0.5129 (0.0204)
MiME aux 0.2831 (0.0425) 0.3651 (0.0473) 0.4047 (0.0276) 0.5142 (0.0210)
in terms of both test loss and test ROC-AUC, except Med2Vec. Moreover, MiME aux always showed
better performance than MiME except test loss inE4, especially for the smallest datasetE1, confirming
our assumption that auxiliary tasks can train a robust model when large datasets are unavailable.
tanhmlp consistently showed good performance in terms of ROC-AUC across all datasets, as opposed
to showing fluctuating PR-AUC in Table 7. Med2Vec again showed a competitive ROC-AUC in all
datasets, even outperforming MiME aux in E3. This suggests that initializing MiME’s code embeddings
with Med2Vec can be an interesting future direction as it may lead to an even better performance.
Table 8: Test loss of HF prediction for increasing data size. Parentheses denote standard deviations
from 5-fold random data splits. Two best values in each column are marked bold.
E1 (6299 patients) E2 (15794 patients) E3 (21128 patients) E4 (27428 patients)
raw 0.2204 (0.0090) 0.2236 (0.0166) 0.2387 (0.0045) 0.2658 (0.0095)
linear 0.2229 (0.0078) 0.2245 (0.0160) 0.2395 (0.0068) 0.2642 (0.0099)
sigmoid 0.2229 (0.0064) 0.2215 (0.0135) 0.2373 (0.0034) 0.2655 (0.0095)
tanh 0.2232 (0.0082) 0.2217 (0.0142) 0.2396 (0.0068) 0.2629 (0.0098)
relu 0.2253 (0.0058) 0.2236 (0.0134) 0.2436 (0.0104) 0.2637 (0.0104)
sigmoidmlp 0.2487 (0.0109) 0.2681 (0.0140) 0.2964 (0.0054) 0.3335 (0.0063)
tanhmlp 0.2198 (0.0058) 0.2259 (0.0156) 0.2358 (0.0024) 0.2616 (0.0111)
relumlp 0.2175 (0.0067) 0.2263 (0.0144) 0.2402 (0.0037) 0.2668 (0.0090)
Med2Vec 0.2162 (0.0091) 0.2141 (0.0171) 0.2340 (0.0043) 0.2631 (0.0106)
GRAM 0.2321 (0.0118) 0.2291 (0.0154) 0.2382 (0.0036) 0.2663 (0.0071)
MiME 0.2128 (0.0075) 0.2153 (0.0126) 0.2331 (0.0039) 0.2559 (0.0096)
MiME aux 0.2111 (0.0089) 0.2122 (0.0115) 0.2326 (0.0048) 0.2557 (0.0095)
Table 9: Test ROC-AUC of HF prediction for increasing data size. Parentheses denote standard
deviations from 5-fold random data splits. Two best values in each column are marked bold.
E1 (6299 patients) E2 (15794 patients) E3 (21128 patients) E4 (27428 patients)
raw 0.7585 (0.0202) 0.8003 (0.0265) 0.8165 (0.0146) 0.8330 (0.0111)
linear 0.7411 (0.0252) 0.7945 (0.0181) 0.8129 (0.0140) 0.8377 (0.0119)
sigmoid 0.7236 (0.0286) 0.7978 (0.0163) 0.8154 (0.0167) 0.8343 (0.0121)
tanh 0.7419 (0.0247) 0.7943 (0.0186) 0.8121 (0.0146) 0.8388 (0.0117)
relu 0.7366 (0.0267) 0.7891 (0.0197) 0.8105 (0.0210) 0.8353 (0.0123)
sigmoidmlp 0.5191 (0.0269) 0.5356 (0.0365) 0.6013 (0.0082) 0.6628 (0.0176)
tanhmlp 0.7429 (0.0330) 0.7796 (0.0283) 0.8172 (0.0084) 0.8431 (0.0128)
relumlp 0.7496 (0.0425) 0.7837 (0.0217) 0.8047 (0.0131) 0.8331 (0.0100)
Med2Vec 0.7633 (0.0151) 0.8141 (0.0213) 0.8301 (0.0138) 0.8445 (0.0115)
GRAM 0.7575 (0.0218) 0.7828 (0.0228) 0.8077 (0.0107) 0.8313 (0.0083)
MiME 0.7676 (0.0292) 0.8109 (0.0223) 0.8267 (0.0106) 0.8471 (0.0100)
MiME aux 0.7824 (0.0213) 0.8154 (0.0193) 0.8281 (0.0159) 0.8478 (0.0108)
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H Sequential Disease Prediction
Sequential disease prediction In order to test if leveraging EHR’s inherent structure is a strategy
generalizable beyond heart failure prediction, we test MiME’s prediction performance in another
context, namely sequential disease prediction. The objective is to predict the diagnosis codes
occurring in visit V(t+1), given all past visits V(1),V(2), . . . ,V(t). The input features are diagnosis
codes A and treatment codes B, while the output space only consists of diagnosis codes A. This task
is useful for preemptively assessing the patient’s potential future risk [10], but is also appropriate for
assessing how well a model captures the progression of the patient status over time. We used GRU as
the mapping function h(·), and hidden vectors from all timesteps were fed to the softmax function
with |A| output classes to perform sequential prediction.
I Experiment Results for Sequential Disease Prediction
Table 10: Prediction performance for sequential disease prediction. Values in the parentheses denote
standard deviations from 5-fold random data splits. The best value in each column is marked in bold.
Test loss Test recall@5 Test recall@10 Test recall@20
raw 7.2121 (0.0319) 0.5329 (0.0016) 0.6600 (0.0016) 0.7749 (0.0019)
linear 7.1474 (0.0321) 0.5443 (0.0008) 0.6749 (0.0010) 0.7876 (0.0009)
sigmoid 7.3494 (0.0438) 0.5110 (0.0054) 0.6338 (0.0052) 0.7529 (0.0029)
tanh 7.1439 (0.0313) 0.5456 (0.0016) 0.6755 (0.0012) 0.7879 (0.0010)
relu 7.1576 (0.0285) 0.5427 (0.0011) 0.6716 (0.0016) 0.7846 (0.0015)
sigmoidmlp 8.7886 (0.0257) 0.2132 (0.0038) 0.3466 (0.0031) 0.5158 (0.0044)
tanhmlp 7.1392 (0.0302) 0.5470 (0.0010) 0.6788 (0.0006) 0.7926 (0.0009)
relumlp 7.1719 (0.0334) 0.5433 (0.0010) 0.6744 (0.0010) 0.7876 (0.0012)
Med2Vec 7.2429 (0.0283) 0.5317 (0.0011) 0.6583 (0.0020) 0.7752 (0.0016)
GRAM 7.1738 (0.0361) 0.5390 (0.0016) 0.6685 (0.0025) 0.7830 (0.0015)
MiME 7.1224 (0.0326) 0.5496 (0.0010) 0.6815 (0.0009) 0.7945 (0.0014)
After training all models until convergence, performance was measured by sorting the predicted
diagnosis codes for V(t+1) by their prediction values, and calculating Recall@k using the true
diagnosis codes of V(t+1).
Table 10 shows the performance of all models for sequential disease prediction. MiME demonstrated
the best performance in all metrics, showing that MiME can properly capture the temporal progression
of the patient status. It is noteworthy that linear displayed very competitive performance compared
to the best performing models. This is due to the fact that chronic conditions such as hypertension or
diabetes persist over a long period of time, and sequentially predicting them becomes an easy task
that does not require an expressive model. This was also reported in [10] where a strategy to choose
the most frequent diagnosis code as the prediction showed competitive performance in a similar task.
In order to study whether explicitly incorporating the structure of EHR helps when there are small data
volume, we calculated the test performance in terms of Precision@5 for predicting each diagnosis
(Dx) code of A. In Table 11, we report average Precision@5 for four different groups of Dx codes,
where the groups were formed by the rarity/frequency of the Dx codes in the training data. For
example, the first column represents the Dx codes that appear in the 0.01%-0.05% of the entire visits
(433407) in the training data, which are very rare diseases. On the other hand, the Dx codes in the last
column appear in maximum 13.39% of the visits, indicating high-prevalence diseases. We selected
the best performing activation function tanh among the three.
As can be seen from Table 11, except for the rarest Dx codes, MiME outperforms all other baseline
models, as much as 11.6% relative gain over tanhmlp. It is notable that Med2Vec demonstrated
the greatest performance for the rarest Dx code group. However, the benefit of using pre-trained
embedding vectors quickly diminishes to the point of degrading the performance when there are at
least several hundred training samples.
Overall, MiME demonstrated good performance in prediction tasks in diverse settings, and it is notable
that they significantly outperformed the baseline models in the more complex task, namely HF
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Table 11: Accuracy@5 for predicting diseases grouped by their rarity. The prevalence percentages
are calculated by dividing the number of occurrences of each disease by 433407, the total number of
visits in the training data. All values are averaged from 5-fold cross validation.
Model 20th-40th percentile(0.01%-0.05% preval)
40th-60th percentile
(0.05%-0.2% preval)
60th-80th percentile
(0.2%-0.8% preval)
80th-100th percentile
(0.8%-13.4% preval)
raw 0.0530 (0.0156) 0.1907 (0.0128) 0.2999 (0.0039) 0.4304 (0.0052)
linear 0.0633 (0.0203) 0.2162 (0.0163) 0.3266 (0.0053) 0.4388 (0.0051)
tanh 0.0674 (0.0182) 0.2101 (0.0143) 0.3218 (0.0045) 0.4379 (0.0033)
tanhmlp 0.0723 (0.0165) 0.2353 (0.0118) 0.3388 (0.0044) 0.4381 (0.0034)
Med2Vec 0.1156 (0.0101) 0.2240 (0.0155) 0.3177 (0.0076) 0.4217 (0.0046)
GRAM 0.0574 (0.0121) 0.1634 (0.0057) 0.3053 (0.0089) 0.4409 (0.0039)
MiME 0.0965 (0.0154) 0.2625 (0.0209) 0.3597 (0.0082) 0.4447 (0.0034)
prediction, where the relationship between the label and the features (i.e. codes) from the data was
more than straightforward.
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